Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Natural anti-epilepsy activity compound and uses of the natural anti-epilepsy activity compound in pharmaceutical preparations

A compound and anti-epileptic technology, applied in the field of biomedicine, can solve problems such as unknown targets, difficulty in quality control, and complex components of Qingyangshen Tablets

Active Publication Date: 2016-04-20
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the composition of Qingyangshen Tablets is complex, which brings certain difficulties to quality control, and the target of action is unknown. Clinically, it is mainly used in combination with antiepileptic drugs such as phenytoin or phenobarbital.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Natural anti-epilepsy activity compound and uses of the natural anti-epilepsy activity compound in pharmaceutical preparations
  • Natural anti-epilepsy activity compound and uses of the natural anti-epilepsy activity compound in pharmaceutical preparations
  • Natural anti-epilepsy activity compound and uses of the natural anti-epilepsy activity compound in pharmaceutical preparations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0170] Evaluation of antiepileptic effect of compound cynawilfosideA (formula VI) in vivo:

[0171] The preparation method of the compound cynawilfoside A: 10 kg of fresh Geshanxiao roots, peeled, sliced ​​and dried to obtain 2.7kg of dry product, crushed and extracted three times with 95% ethanol percolation, each time for 2 to 3 days, combined extracts, concentrated under reduced pressure to obtain Geshanxiao the alcoholic extract, suspend the extract in water, extract with ethyl acetate, get the ethyl acetate extract, mix the sample with 100 mesh silica gel, separate with silica gel column chromatography (200-300 mesh silica gel), separate with chloroform-methanol (10:1→5:1) gradient elution to obtain components Fr1-Fr9. Fr6 was further purified repeatedly with petroleum ether-acetone and preparative HPLC to obtain pure compound cynawilfosideA (1.4 g).

[0172]

[0173] The physical and chemical data of the compound cynawilfoside A are as follows: white amorphous powder...

Embodiment 2

[0178] Evaluation of compound wilfosideC1N (formula IV) antiepileptic effect in vivo:

[0179] The preparation method of Wilfoside C1N: a. fresh 10kg of Auricularia spp., sliced ​​and dried to obtain 3Kg dry product, pulverized and extracted three times with 95% ethanol, the extracts were combined, concentrated under reduced pressure to obtain ethanol extract, mixed with silica gel, passed 200 -300 mesh silica gel, gradient elution with petroleum ether-acetone (3:1→2:1), and then gradient elution with chloroform-methanol (10:1→5:1) to obtain fractions Fr1-Fr6. Fr3 was further purified repeatedly by petroleum ether-acetone silica gel column chromatography to obtain pure compound wilfosideC1N (1.5g); b. 10kg of fresh Geshanxiao root, peeled, sliced ​​and dried to obtain 2.7kg of dry product, pulverized and extracted by percolation with 95% ethanol Three times, 2 to 3 days each time, combine the extracts, concentrate under reduced pressure to obtain the alcohol extract of Geshanx...

Embodiment 3

[0185] Evaluation of compound wilfosideK1N (formula V) antiepileptic effect in vivo:

[0186] The preparation method of Wilfoside K1N: a. 10kg of fresh cowhide tuber, sliced ​​and dried to obtain 3kg dry product, crushed and extracted three times with 95% ethanol, the extracts were combined, concentrated under reduced pressure to obtain ethanol extract, mixed with silica gel, passed 200-300 Mesh silica gel, gradient elution with petroleum ether-acetone (3:1→2:1), and then gradient elution with chloroform-methanol (10:1→5:1) to obtain fractions Fr1-Fr6. Fr3 was further purified repeatedly by petroleum ether-acetone silica gel column chromatography to obtain pure compound wilfosideK1N (2.5g); b. 10kg of fresh Geshanxiao root, peeled, sliced ​​and dried to obtain 2.7kg dry product, pulverized and extracted by percolation with 95% ethanol Three times, 2 to 3 days each time, combine the extracts, concentrate under reduced pressure to obtain the alcohol extract of Geshanxiao, suspen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a natural anti-epilepsy activity compound and uses of the natural anti-epilepsy activity compound in pharmaceutical preparations. The present invention discloses different monomer compounds having diametrically opposed effects such as epilepsy promoting and epilepsy resistance in Cynanchum otophyllum. According to the present invention, particularly the single component is respectively extracted from Cynanchum, C.auriculatum Royle exWight and C.wilfordii Hemsl, and experiment results prove that each compound has anti-epilepsy activity.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular, the invention relates to natural antiepileptic active compounds and their application in pharmaceutical preparations. Background technique [0002] Epilepsy, also known as cerebral epilepsy or sheep epilepsy, is a syndrome of chronic recurrent transient brain dysfunction. According to statistics, the incidence of epilepsy in my country is about 23 / 100,000 per year, and the prevalence rate is 3.5‰-4.8‰. Seizures can cause a series of symptoms, and convulsions are one of the typical symptoms of epilepsy, including repetitive movements of limbs, abnormal behavior, and general convulsions with loss of consciousness, etc., and even cause body damage or death. The treatment of epilepsy includes various methods such as drug therapy, surgical therapy, physical therapy and psychotherapy, among which drug therapy is the most commonly used and most important means at present. Currently clinically...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J17/00A61K31/704A61P25/08G01N33/15
Inventor 赵维民周娟李金龙李春启陈振华张勇高召兵郭胜亚
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com